Microarray technology could help predict patient response to adjuvant therapy for breast cancer
2nd Oct 2005, 23:29 GMT
Microarray technology could be used to tailor therapy according to theindividual, and prevent breast cancer patients from having to undergo painfulunsuccessful therapies. In a study published in the journal Breast CancerResearch, researchers analysed tumour tissue samples and identified a group of64 genes that can be used to predict a patient's response in the five yearsafter adjuvant therapy for breast cancer.
Microarray technology could help predict patient response to adjuvant therapy for breast cancer related news:
- Microarray technology could help predict patient response to adjuvant therapy for breast cancer — KeralaNext: Science
- Gene Profiling May Improve Breast Cancer Care (HealthDay) — Yahoo! Health: Health News
- Gene Profiling May Improve Breast Cancer Care — Rednova News - Health
- Microarray technology for tailoring breast cancer therapy — EurekAlert! - Cancer
- FDA approves Pfizer's adjuvant breast cancer treatment — Pharmaceutical Business Review Online
- Hormone Replacement Therapy Raises Breast Density (HealthDay) — Yahoo! Health: Breast Cancer News
- My Personal Journey With Breast Cancer — Breast Cancer Chronicles
- FDA Approves Pfizer's Aromasin for Adjuvant Treatment of Early Breast Cancer in Postmenopausal Women — Radiology News from StratCenter.com
- Call to stop exposing women to breast cancer risk by needlessly using radiation therapy as a component of Hodgkin disease treatment — News-Medical News Feed
- Beating breast cancer - October is Breast Cancer Awareness Month — Medical News Today RSS/XML Feed
Latest news from EurekAlert! - Cancer:
- Targeted cancer drugs may work by disrupting balance of cellular signals
- Studies examine colorectal cancer screening rates
- Higher red meat intake may increase risk for certain breast cancers
- U-M researchers use nanoparticles to target brain cancer
- 'Trojan Horse' agent halts bone metastasis in mice
- Increased patient demand for prostate test has serious implications for cancer services
- Novel regulatory mechanism identified for key tumor suppressor p53